Atlas Trials

E.V.O.L.V.E. Trial™: EValuation Of Cinacalcet Hydrochloride (HCl) Therapy to Lower CardioVascular Events

Clinical trial NCT00345839 · COMPLETED

Trial details

NCT number
NCT00345839
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Secondary HyperparathyroidismChronic Kidney Disease
Start date
2006-08-22
Primary completion
2012-04-10
Enrollment
3883

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.